U.S. will donate substantial portion of vaccines through COVAX -U.S. official
Reuters
Published May 19, 2021 08:03AM ET
Updated May 19, 2021 08:22AM ET
BRUSSELS (Reuters) -The United States will donate a significant number of COVID-19 vaccines through the World Health Organization's COVAX scheme for distributing doses to poorer countries, the U.S. global coordinator on COVID Gayle Smith told a news conference.
U.S. President Joe Biden announced on Monday that his administration will send by the end of June a total of 20 million doses of the Pfizer (NYSE:PFE) Inc/BioNTech SE, Moderna (NASDAQ:MRNA) Inc and Johnson & Johnson (NYSE:JNJ) vaccines, on top of 60 million AstraZeneca (NASDAQ:AZN) Plc doses he had already planned to give to other countries.
"The allocation of the vaccines will include obviously a substantial portion through COVAX, but we have not made final decisions," Smith said on Wednesday, adding that no decision was made either on where doses could be sent.
Smith said that the United States was also planning to increase its funding for COVAX, in addition to $2 billion which she said it had already donated to the facility in past months.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.